? Administrative Core The Administrative Core provides comprehensive administrative and scientific management for all components of the Duke Brain SPORE, including research Projects 1-3, three Shared Resource Cores, and both Developmental Research and Career Enhancement Programs. Programmatic oversight will be provided by the Administrative Core Co-Leads, as well as an Executive Committee consisting of Project and Core Leads and Internal and External Advisory Boards. The functions of the Administrative Core will be carried out through the following Specific Aims: 1) Provide administrative management and oversight; 2) Provide financial management and ensure compliance with fiscal and research policies; 3) Provide oversight of all data operations; 4) To promote integration within the SPORE and the Institution; 5) Maintain and support access to an adequate cancer patient population; and 6) Provide scientific management and evaluate research progress. Through these Aims, the Core ensures the full range of support required to provide administrative management; promote integration, communication, and collaboration; ensure fiscal and regulatory compliance; and oversee data operations, scientific rigor, and research progress. By serving these functions, the Administrative Core allows SPORE investigators to focus on conducting and advancing the translational science supported by the SPORE.

Public Health Relevance

? Administrative Core Primary brain tumors are the most frequent cause of cancer death in children and young adults. This Administrative Core provides infrastructure, leadership, coordination, integration, and oversight for the Duke SPORE in Brain Cancer to enable its translational research designed to improve outcomes for patients with primary brain tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA190991-06
Application #
9632607
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Dobrikov, Mikhail I; Dobrikova, Elena Y; Gromeier, Matthias (2018) Ribosomal RACK1:Protein Kinase C ?II Modulates Intramolecular Interactions between Unstructured Regions of Eukaryotic Initiation Factor 4G (eIF4G) That Control eIF4E and eIF3 Binding. Mol Cell Biol 38:
Ding, Yi; Gong, Chang; Huang, De et al. (2018) Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers. Nat Commun 9:4274
Dobrikov, Mikhail I; Dobrikova, Elena Y; Gromeier, Matthias (2018) Ribosomal RACK1:Protein Kinase C ?II Phosphorylates Eukaryotic Initiation Factor 4G1 at S1093 To Modulate Cap-Dependent and -Independent Translation Initiation. Mol Cell Biol 38:
Desjardins, Annick; Gromeier, Matthias; Herndon 2nd, James E et al. (2018) Recurrent Glioblastoma Treated with Recombinant Poliovirus. N Engl J Med 379:150-161
Gromeier, Matthias; Nair, Smita K (2018) Recombinant Poliovirus for Cancer Immunotherapy. Annu Rev Med 69:289-299
Lin, Jiaxing; Gresham, Jeremy; Wang, Tongrong et al. (2018) bcSeq: an R package for fast sequence mapping in high-throughput shRNA and CRISPR screens. Bioinformatics 34:3581-3583
Swartz, Adam M; Reap, Elizabeth; Norberg, Pamela et al. (2018) A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis. J Immunol Methods 459:90-93
Chong, Mengyang; Yin, Tao; Chen, Rui et al. (2018) CD36 initiates the secretory phenotype during the establishment of cellular senescence. EMBO Rep 19:
Thompson, Eric M; Brown, Michael; Dobrikova, Elena et al. (2018) Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma. J Neuropathol Exp Neurol 77:696-702
Woroniecka, Karolina; Chongsathidkiet, Pakawat; Rhodin, Kristen et al. (2018) T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clin Cancer Res 24:4175-4186

Showing the most recent 10 out of 39 publications